Next Article in Journal
Cutaneous Protothecosis in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review
Open AccessEditorial

Welcome Message from the Editor-in-Chief

Public Health Research Institute (PHRI), International Center for Public Health, New Jersey Medical School, Rutgers, the State University of New Jersey, 225 Warren Street, Newark, NJ 07103, USA
J. Fungi 2015, 1(1), 1-3;
Received: 7 July 2014 / Accepted: 7 July 2014 / Published: 16 July 2014
Note: In lieu of an abstract, this is an excerpt from the first page.

Fungi are one of the most important and diverse groups of organisms on the planet, having a dual impact on humanity. They adversely impact human and animal health and can be a scourge to agriculture, while in turn serving as a beneficial source for foods and beverages, new medications, and biocontrol. There are approximately 1.5 million different species of fungi on Earth, which largely reside in soil and plant. They are also readily found on human skin and within the gastrointestinal and genitourinary tract, yet only about 300 species are known to make people sick [1,2]. Fungi are bountiful in the environment and we encounter them everyday, usually in the form of freely dispersed spores and hyphal fragments that we breath-in. Typically, encounters with fungi are harmless, as the human immune systems is well poised to handle such interactions. However, some fungal species pose significant health risks, such as endemic mycoses or those producing toxins like mycotoxins. Most importantly, immune dysfunction can lead to serious life-threatening diseases or severe fungal-induced allergic diseases such as asthma or other chronic conditions [3]. In fact, most invasive fungal diseases are associated with changes in the host such as immunosuppression, antibiotic-mediated disruption of microflora, or other immunosuppressing conditions resulting from HIV/AIDS and hematologic malignancies [3,4]. Such diseases require therapy with antifungal agents. Yet, there are only limited classes available to treat invasive fungal infection, and emerging drug resistance further restricts treatment options. In some cases, agents used to control agriculturally important moulds are the same class as those used to treat humans, and de novo resistance can emerge from the environment [5]. Fungi are not always easy to detect and cryptic chronic infections in the form of unculturable organisms can confound diagnosis [6]. [...] View Full-Text
MDPI and ACS Style

Perlin, D.S. Welcome Message from the Editor-in-Chief. J. Fungi 2015, 1, 1-3.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop